News
June 15, 2025 - Sacramento, CA – In response to the Trump Administration’s move to provide deportation officials with the personal data of Medicaid enrollees, health care provider groups across ...
The U.S. Department of Veterans Affairs is taking aim at homelessness and its related issues affecting America's veteran ...
In other words, the businesses were planning to pass the costs along to the customer, something no one in the country ...
Merus initially surged on superior interim trial data, while Bicara Therapeutics tanked. Click here to find out why BCAX ...
Rhythm Technologies, Inc.'s Q1 2025 growth, AI innovations, and market expansion. Click for why I upgraded IRTC to Buy ...
Fast Track Designation (FTD) granted for the treatment of patients with metastatic PDAC with high IL1RAP expression levels.Reflects high unmet medical need in metastatic PDAC.Facilitates further devel ...
Databricks CEO Ali Ghodsi lauds India's advanced digital infrastructure, surpassing many nations and fostering innovation in ...
WASHINGTON — Trump administration officials are expected to release more details on their plan to lower prescription drug ...
“Under no pressure and no response to any protest, they offered themselves a $2 billion commitment to the Black community and Black entrepreneurs, and then after the inauguration of Donald Trump, ...
Sometimes, it's better to wait before expanding a brand into retail. Here is why retail doesn’t build brands, it exposes them.
Tesla ( TSLA 5.66%) stock has tumbled 22% year to date amid a myriad of business and political headwinds, and Wall Street ...
TuHURA Biosciences advances its phase 3 trial of IFx-2.0 for Merkel cell carcinoma, aiming to enhance immune response alongside pembrolizumab.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results